HealthTech
InnoCan Pharma Continues to Display Resilience and Innovation with Impressive Q1 Results
InnoCan Pharma Corporation reported strong revenue growth for the first quarter that ended March 31, 2022, demonstrating the favorable operating conditions enjoyed...
